Compare Sanofi SA (SNY) vs Direxion Daily Semiconductor Bull 3X Shares (SOXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Sanofi SA trades at $40.04 (market cap $95.18B), while Direxion Daily Semiconductor Bull 3X Shares trades at $139.8 (market cap $24.42B). The key difference: Sanofi SA is far larger — about 3.9× Direxion Daily Semiconductor Bull 3X Shares's market cap, and Sanofi SA pays a 6.01% dividend while Direxion Daily Semiconductor Bull 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sanofi SA for 94 Days and Direxion Daily Semiconductor Bull 3X Shares for 15 Days on average.
| SNY | SOXL | |
|---|---|---|
Market Cap | $95.18B | $24.42B |
Volume | 2,995,646 | 100,232,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $52.34 | $300.77 |
52-Week Low | $39.51 | $30.81 |
Typical Hold Time | 94 Days | 15 Days |
Enterprise Value | $114.48B | — |
Dividend Yield | 6.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sanofi (SNY) trades at $40.07, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.21 exceeding the $1.10 estimate. Revenue for 2025 reached $46.72 billion, with a net income margin of 16.72%. Recent news highlights a significant $8 billion immunology alliance expansion with Regeneron, signaling strategic growth initiatives.
The outlook is mixed; solid profitability and a strategic partnership provide upside potential, but a projected net income decline to $4.0 billion in 2026 and bearish technical indicators pose risks. Analyst sentiment is cautiously optimistic with a 44% buy rating, though investors should monitor execution of new collaborations and patent expiration impacts.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, is trading at $139.76, down 12.05% with a bearish technical signal. The fund faces volatility from its 3x leverage on semiconductor stocks, which have shown mixed performance amid strong AI demand but regulatory and market risks. Recent news highlights sector rebounds and institutional selling, while technical indicators show neutral oscillators and key support at $134.
Outlook is cautious due to leverage amplifying sector swings; opportunities exist if semiconductor fundamentals hold, but risks include tariff concerns and overcrowded trades. Investors should weigh high volatility against AI-driven growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About Direxion Daily Semiconductor Bull 3X Shares
SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →
